H2 receptor antagonists (H2RAs) function by competitively inhibiting histamine binding at H2 receptors on gastric parietal cells, thereby reducing gastric acid secretion. This pharmacological class includes famotidine, nizatidine, cimetidine, and ranitidine (though ranitidine was withdrawn from the US market in 2020 due to NDMA contamination concerns).
H2RAs are indicated for various acid-related disorders including gastroesophageal reflux disease (GERD), peptic ulcer disease (both gastric and duodenal), prevention of NSAID-induced gastropathy, stress ulcer prophylaxis in critically ill patients, and management of hypersecretory conditions such as Zollinger-Ellison syndrome. They also provide symptomatic relief for non-ulcer dyspepsia and can be used perioperatively to reduce aspiration risk.
While generally well-tolerated, H2RAs may cause adverse effects including headache, dizziness, fatigue, constipation, and diarrhea. Cimetidine notably inhibits cytochrome P450 enzymes, resulting in significant drug interactions. Rare but serious adverse effects include altered mental status in elderly patients, thrombocytopenia, and hepatotoxicity.
Lecture Objectives:
List the primary clinical applications of H2 blockers.
Identify the common and less common side effects associated with H2 receptor antagonist use.
Faculty
In addition to the presenter, following authors may have helped with the content writing, review,
or approval:
CME, CE, CEU and Other Credit Types:
ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.
AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.5 AMA PRA Category 1
Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Disclosure Information
In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for
Continuing Medical Education), we are committed to upholding principles of balance, independence,
objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing
Education (CE) activities. These policies include the careful management and mitigation of any relevant
financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial
relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined
that these relationships are not deemed inappropriate in the context of their respective presentations.
Additionally, they are found to be consistent with the educational objectives and the integrity of the
activity.
| Faculty |
Disclosures |
|
Author declares no conflict of interest. |
Write A New Comment
1 Comments
deborahdenisesharp@*.com
Mar 28 2025, 11:17 am
Hi - The video says it cannot be viewed "because of privacy settings". (?)